Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rukmini Bhardwaj

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Translational Medicine|December 22, 2018
Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathwayRukmini Bhardwaj, Akiko Suzuki, Pamela Leland, et al.
Protein Expression and Purification|November 19, 2015
Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine developmentRukmini Bhardwaj, Ahmad Rushdi Shakri, Dhiraj Hans, et al.
Vaccine|June 21, 2015
ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humansKa Yan Chung, Elizabeth M Coyle, Dewal Jani, et al.
Science Translational Medicine|July 29, 2011
Targeting TLRs expands the antibody repertoire in response to a malaria vaccineSteven R Wiley, Vanitha S Raman, Anthony Desbien, et al.
Plos One|March 19, 2021
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysisLili Wang, Rukmini Bhardwaj, Howard Mostowski, et al.
Plos Neglected Tropical Diseases|February 16, 2019
Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical MalariaWen-Qiang He, Ahmad Rushdi Shakri, Rukmini Bhardwaj, et al.
Plos One|September 3, 2015
Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, et al.
Plos One|May 1, 2015
Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, et al.
NPJ Vaccines|October 11, 2018
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trialKavita Singh, Paushali Mukherjee, Ahmad Rushdi Shakri, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Translational Medicine|December 22, 2018
Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathwayRukmini Bhardwaj, Akiko Suzuki, Pamela Leland, et al.
Protein Expression and Purification|November 19, 2015
Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine developmentRukmini Bhardwaj, Ahmad Rushdi Shakri, Dhiraj Hans, et al.
Vaccine|June 21, 2015
ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humansKa Yan Chung, Elizabeth M Coyle, Dewal Jani, et al.
Science Translational Medicine|July 29, 2011
Targeting TLRs expands the antibody repertoire in response to a malaria vaccineSteven R Wiley, Vanitha S Raman, Anthony Desbien, et al.
Plos One|March 19, 2021
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysisLili Wang, Rukmini Bhardwaj, Howard Mostowski, et al.
Plos Neglected Tropical Diseases|February 16, 2019
Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical MalariaWen-Qiang He, Ahmad Rushdi Shakri, Rukmini Bhardwaj, et al.
Plos One|September 3, 2015
Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, et al.
Plos One|May 1, 2015
Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, et al.
NPJ Vaccines|October 11, 2018
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trialKavita Singh, Paushali Mukherjee, Ahmad Rushdi Shakri, et al.
Pageof 1